MINAPHARM Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
MINAPHARM Pharmaceuticals has a total shareholder equity of EGP3.4B and total debt of EGP3.1B, which brings its debt-to-equity ratio to 90.8%. Its total assets and total liabilities are EGP8.0B and EGP4.6B respectively. MINAPHARM Pharmaceuticals's EBIT is EGP899.3M making its interest coverage ratio 7. It has cash and short-term investments of EGP1.7B.
Debt to equity ratio
|Interest coverage ratio
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: MIPH's short term assets (EGP3.7B) exceed its short term liabilities (EGP3.1B).
Long Term Liabilities: MIPH's short term assets (EGP3.7B) exceed its long term liabilities (EGP1.5B).
Debt to Equity History and Analysis
Debt Level: MIPH's net debt to equity ratio (41.7%) is considered high.
Reducing Debt: MIPH's debt to equity ratio has increased from 61.8% to 90.8% over the past 5 years.
Debt Coverage: MIPH's debt is not well covered by operating cash flow (10.6%).
Interest Coverage: MIPH's interest payments on its debt are well covered by EBIT (7x coverage).